Green Lifescience Balance Sheet Health
Financial Health criteria checks 5/6
Green Lifescience has a total shareholder equity of ₩36.0B and total debt of ₩4.8B, which brings its debt-to-equity ratio to 13.4%. Its total assets and total liabilities are ₩43.8B and ₩7.9B respectively.
Key information
13.4%
Debt to equity ratio
₩4.80b
Debt
Interest coverage ratio | n/a |
Cash | ₩14.45b |
Equity | ₩35.95b |
Total liabilities | ₩7.87b |
Total assets | ₩43.83b |
Financial Position Analysis
Short Term Liabilities: A114450's short term assets (₩21.7B) exceed its short term liabilities (₩7.4B).
Long Term Liabilities: A114450's short term assets (₩21.7B) exceed its long term liabilities (₩480.9M).
Debt to Equity History and Analysis
Debt Level: A114450 has more cash than its total debt.
Reducing Debt: A114450's debt to equity ratio has increased from 8.6% to 13.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A114450 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A114450 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 19.9% each year